Hims & Hers shares plunge as looming curbs on drug compounding cloud forecast
Hims & Hers Health shares were headed for their biggest single-day plunge as Wall Street analysts questioned the telehealth ...
Hims & Hers stock tumbles
Hims & Hers will stop selling generic semaglutide after the FDA said the shortage of GLP-1 medications is resolved.
Hosted on MSN38m
HIMS Stock Declines Following Q4 Earnings Miss, Gross Margin Contracts
Hims & Hers Health, Inc. HIMS delivered an earnings per share (EPS) of 11 cents in fourth-quarter 2024, compared with the ...
BioPharma Dive40m
Drug compounders sue FDA over declaration ending Wegovy shortage
Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” ...
SchaeffersResearch.com56m
Market Turns Lower After Consumer Confidence Data
Stocks are pulling back sharply from their premarket gains, after this morning's consumer confidence reading came in at 98.3 for February. This is well below expectations of 102.3 and a 7-point drop, ...